{"id":"https://openalex.org/W4387599152","doi":"https://doi.org/10.1158/1535-7163.mct-23-0217","title":"Delivery versus Potency in Treating Brain Tumors: BI-907828, a MDM2-p53 Antagonist with Limited BBB Penetration but Significant In Vivo Efficacy in Glioblastoma","display_name":"Delivery versus Potency in Treating Brain Tumors: BI-907828, a MDM2-p53 Antagonist with Limited BBB Penetration but Significant In Vivo Efficacy in Glioblastoma","alternate_titles":[],"publication_year":2023,"publication_date":"2023-10-12","ids":{"openalex":"https://openalex.org/W4387599152","doi":"https://doi.org/10.1158/1535-7163.mct-23-0217","pmid":"https://pubmed.ncbi.nlm.nih.gov/37828724","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10843165"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-23-0217","doi":"https://doi.org/10.1158/1535-7163.mct-23-0217","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-23-0217","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4387599152"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10843165/pdf/nihms-1938771.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100454482","display_name":"Wenjuan Zhang","orcid":"https://orcid.org/0000-0001-6972-6449","observed_orcids":["https://orcid.org/0000-0001-6972-6449","https://orcid.org/0009-0008-6747-3941"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wenjuan Zhang","raw_affiliation_strings":["1Brain Barriers Research Center, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota"],"raw_orcid":"https://orcid.org/0000-0001-6972-6449","affiliations":[{"raw_affiliation_string":"1Brain Barriers Research Center, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032385201","display_name":"Rachael A. Vaubel","orcid":"https://orcid.org/0000-0001-8842-5975","observed_orcids":["https://orcid.org/0000-0001-8842-5975"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rachael A. Vaubel","raw_affiliation_strings":["2Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota"],"raw_orcid":"https://orcid.org/0000-0001-8842-5975","affiliations":[{"raw_affiliation_string":"2Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053759310","display_name":"Ju-Hee Oh","orcid":"https://orcid.org/0009-0002-2181-0590","observed_orcids":["https://orcid.org/0009-0002-2181-0590"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ju-Hee Oh","raw_affiliation_strings":["1Brain Barriers Research Center, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota"],"raw_orcid":"https://orcid.org/0009-0002-2181-0590","affiliations":[{"raw_affiliation_string":"1Brain Barriers Research Center, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089932442","display_name":"Ann C. Mladek","orcid":"https://orcid.org/0000-0002-0508-6531","observed_orcids":["https://orcid.org/0000-0002-0508-6531"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ann C. Mladek","raw_affiliation_strings":["2Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota"],"raw_orcid":"https://orcid.org/0000-0002-0508-6531","affiliations":[{"raw_affiliation_string":"2Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042944026","display_name":"Surabhi Talele","orcid":"https://orcid.org/0009-0008-1604-1233","observed_orcids":["https://orcid.org/0009-0008-1604-1233"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Surabhi Talele","raw_affiliation_strings":["1Brain Barriers Research Center, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota"],"raw_orcid":"https://orcid.org/0009-0008-1604-1233","affiliations":[{"raw_affiliation_string":"1Brain Barriers Research Center, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038473646","display_name":"Wenqiu Zhang","orcid":"https://orcid.org/0009-0001-8732-8409","observed_orcids":["https://orcid.org/0009-0001-8732-8409"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wenqiu Zhang","raw_affiliation_strings":["1Brain Barriers Research Center, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota"],"raw_orcid":"https://orcid.org/0009-0001-8732-8409","affiliations":[{"raw_affiliation_string":"1Brain Barriers Research Center, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068180184","display_name":"Katie L. Waller","orcid":"https://orcid.org/0009-0004-2275-4062","observed_orcids":["https://orcid.org/0009-0004-2275-4062"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katie L. Waller","raw_affiliation_strings":["2Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota"],"raw_orcid":"https://orcid.org/0009-0004-2275-4062","affiliations":[{"raw_affiliation_string":"2Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040880361","display_name":"Danielle M. Burgenske","orcid":"https://orcid.org/0000-0003-0014-5579","observed_orcids":["https://orcid.org/0000-0003-0014-5579"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Danielle M. Burgenske","raw_affiliation_strings":["2Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota"],"raw_orcid":"https://orcid.org/0000-0003-0014-5579","affiliations":[{"raw_affiliation_string":"2Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015247761","display_name":"Jann Nagina Sarkaria","orcid":"https://orcid.org/0000-0001-7489-4885","observed_orcids":["https://orcid.org/0000-0001-7489-4885"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jann N. Sarkaria","raw_affiliation_strings":["2Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota"],"raw_orcid":"https://orcid.org/0000-0001-7489-4885","affiliations":[{"raw_affiliation_string":"2Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037781231","display_name":"William F. Elmquist","orcid":"https://orcid.org/0000-0002-7478-3429","observed_orcids":["https://orcid.org/0000-0002-7478-3429"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"William F. Elmquist","raw_affiliation_strings":["1Brain Barriers Research Center, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota"],"raw_orcid":"https://orcid.org/0000-0002-7478-3429","affiliations":[{"raw_affiliation_string":"1Brain Barriers Research Center, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota","institution_ids":["https://openalex.org/I130238516"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5015247761","https://openalex.org/A5037781231"],"corresponding_institution_ids":["https://openalex.org/I130238516","https://openalex.org/I1330342723"],"apc_list":null,"apc_paid":null,"fwci":1.1757,"has_fulltext":true,"cited_by_count":11,"citation_normalized_percentile":{"value":0.7799924,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"23","issue":"1","first_page":"47","last_page":"55"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.8895999789237976,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.8895999789237976,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.0729999989271164,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.025100000202655792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bi-907828","display_name":"BI 907828","score":0.9990000128746033},{"id":"https://openalex.org/keywords/p53-mdm2-pathway","display_name":"MDM2-p53 pathway","score":0.8360000252723694},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9660000205039978},{"id":"https://openalex.org/keywords/blood-brain-barrier-penetration","display_name":"blood-brain barrier penetration","score":0.9549999833106995},{"id":"https://openalex.org/keywords/p-glycoprotein-efflux","display_name":"P-glycoprotein efflux","score":0.9229999780654907},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8479999899864197},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9169999957084656},{"id":"https://openalex.org/keywords/unbound-drug-concentration","display_name":"unbound drug concentration","score":0.7459999918937683},{"id":"https://openalex.org/keywords/mdm2-amplification","display_name":"MDM2 amplification","score":0.8539999723434448},{"id":"https://openalex.org/keywords/orthotopic-xenograft-model","display_name":"orthotopic xenograft","score":0.8259999752044678},{"id":"https://openalex.org/keywords/drug-potency","display_name":"drug potency","score":0.44999998807907104},{"id":"https://openalex.org/keywords/central-nervous-system-tumors","display_name":"central nervous system tumors","score":0.7269999980926514}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7225797772407532},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.7050999402999878},{"id":"https://openalex.org/C2776192174","wikidata":"https://www.wikidata.org/wiki/Q18028978","display_name":"Mdm2","level":3,"score":0.6594186425209045},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.644931435585022},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6290985941886902},{"id":"https://openalex.org/C2778402981","wikidata":"https://www.wikidata.org/wiki/Q221694","display_name":"Blood\u2013brain barrier","level":3,"score":0.5864241123199463},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.5154048204421997},{"id":"https://openalex.org/C200082930","wikidata":"https://www.wikidata.org/wiki/Q22327148","display_name":"Efflux","level":2,"score":0.43437108397483826},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.4263834059238434},{"id":"https://openalex.org/C110121322","wikidata":"https://www.wikidata.org/wiki/Q865811","display_name":"Distribution (mathematics)","level":2,"score":0.4207794964313507},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.390980988740921},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37758350372314453},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3651164174079895},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.29443761706352234},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.2521500289440155},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.23298859596252441},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18973875045776367},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.13426589965820312},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08442077040672302},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001812","descriptor_name":"Blood-Brain Barrier","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D006576","descriptor_name":"Heterocyclic Compounds, 4 or More Rings","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013141","descriptor_name":"Spiro Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051736","descriptor_name":"Proto-Oncogene Proteins c-mdm2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.mct-23-0217","doi":"https://doi.org/10.1158/1535-7163.mct-23-0217","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-23-0217","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:37828724","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37828724","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10843165","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10843165","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10843165/pdf/nihms-1938771.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Mol Cancer Ther","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:10843165","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10843165","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10843165/pdf/nihms-1938771.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Mol Cancer Ther","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G368861938","display_name":"Pre-Clinical Novel Radiosensitizer Evaluation Program for Brain Tumors","funder_award_id":"U01CA227954","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6847690757","display_name":null,"funder_award_id":"AWD0006946 / 21-004061","funder_id":"https://openalex.org/F4320306631","funder_display_name":"National Brain Tumor Society"},{"id":"https://openalex.org/G9000864732","display_name":"Targeting Defective DNA Damage Response Pathways in IDH1/2-mutant AML","funder_award_id":"R01CA266604","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000875073","display_name":"Center of Innovation for Brain Tumor Therapeutics","funder_award_id":"U19CA264362","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306631","display_name":"National Brain Tumor Society","ror":"https://ror.org/051687e73"},{"id":"https://openalex.org/F4320309636","display_name":"University of Minnesota","ror":"https://ror.org/03grvy078"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4387599152.pdf","grobid_xml":"https://content.openalex.org/works/W4387599152.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W1544655463","https://openalex.org/W1650797637","https://openalex.org/W1965478395","https://openalex.org/W1965522214","https://openalex.org/W1988591144","https://openalex.org/W1993170641","https://openalex.org/W2007249806","https://openalex.org/W2017379014","https://openalex.org/W2028387032","https://openalex.org/W2058780134","https://openalex.org/W2098983401","https://openalex.org/W2126799977","https://openalex.org/W2144391411","https://openalex.org/W2162527129","https://openalex.org/W2747736143","https://openalex.org/W2752314762","https://openalex.org/W2752942423","https://openalex.org/W2811177858","https://openalex.org/W2885529106","https://openalex.org/W2887286471","https://openalex.org/W2980414139","https://openalex.org/W3041100082","https://openalex.org/W3081910669","https://openalex.org/W3083455617","https://openalex.org/W3164568596","https://openalex.org/W3168075620","https://openalex.org/W3200259087","https://openalex.org/W4223488441","https://openalex.org/W4226071469","https://openalex.org/W4311662637","https://openalex.org/W4365512117","https://openalex.org/W4402438635"],"related_works":["https://openalex.org/W4392373842","https://openalex.org/W4396850371","https://openalex.org/W2312976755","https://openalex.org/W2811177858","https://openalex.org/W1893358364","https://openalex.org/W2035207048","https://openalex.org/W4411871462","https://openalex.org/W2110604363","https://openalex.org/W1967015427","https://openalex.org/W3083455617"],"abstract_inverted_index":{"MDM2-p53":[0,53,105],"inhibition":[1,103],"may":[2],"be":[3,183],"effective":[4,125],"in":[5,20,39,66,71,95,111,147,189,195,205,240],"glioblastoma":[6],"(GBM).":[7],"This":[8,179],"study":[9],"evaluates":[10],"the":[11,196,231],"pharmacokinetics/pharmacodynamics":[12],"of":[13,18,104,128,134,150,160,167,203,227,230,248],"BI-907828,":[14,122],"a":[15,24,28,31,148,190,224],"potent":[16,102],"antagonist":[17],"MDM2,":[19],"GBM,":[21],"and":[22,52,58,75,90,107,243],"demonstrates":[23],"translational":[25],"paradigm":[26],"with":[27,123],"focus":[29],"on":[30],"unified":[32],"\"Delivery":[33,232],"-":[34,36,233,235],"Potency":[35,234],"Efficacy\"":[37,236],"relationship":[38,237],"drug":[40,241],"development":[41],"for":[42,50,246],"central":[43],"nervous":[44],"system(CNS)":[45],"tumors.":[46,250],"BI-907828":[47,68,100,135,163,204],"was":[48],"tested":[49],"cytotoxicity":[51],"pathway":[54,106],"inhibition.":[55],"Systemic":[56],"pharmacokinetics":[57],"transport":[59],"mechanisms":[60],"controlling":[61],"CNS":[62,132,216,249],"distribution":[63,133,217],"were":[64,78,93],"evaluated":[65],"mice.":[67],"free":[69],"fractions":[70],"cell":[72,109],"media,":[73],"mouse":[74,96],"human":[76],"specimens":[77],"measured":[79],"to":[80,121,173,185,210],"determine":[81],"\"active\"":[82],"unbound":[83,126],"concentrations.":[84],"Efficacy":[85],"measures,":[86],"including":[87],"overall":[88],"survival":[89,166],"target":[91],"expression":[92],"assessed":[94],"orthotopic":[97,168,206],"GBM":[98,112],"xenografts.":[99],"exhibited":[101],"promoted":[108],"death":[110],"TP53":[113],"wild-type":[114],"cells.":[115],"MDM2-amplified":[116],"cells":[117],"are":[118],"highly":[119],"sensitive":[120],"an":[124],"concentration":[127],"0.1":[129],"nmol/L.":[130],"The":[131],"is":[136,208,218,238],"limited":[137,219],"by":[138,144,220],"blood-brain":[139],"barrier":[140],"(BBB)":[141],"efflux":[142],"mediated":[143],"P-gp,":[145],"resulting":[146,188],"Kp,uu_brain":[149],"0.002.":[151],"Despite":[152],"this":[153],"seemingly":[154],"\"poor\"":[155],"BBB":[156,221],"penetration,":[157],"weekly":[158],"administration":[159],"10":[161],"mg/kg":[162],"extended":[164],"median":[165],"GBM108":[169],"xenografts":[170],"from":[171],"28":[172],"218":[174],"days":[175],"(P":[176],"<":[177],"0.0001).":[178],"excellent":[180],"efficacy":[181,202],"can":[182],"attributed":[184],"high":[186,211],"potency,":[187],"limited,":[191],"yet":[192],"effective,":[193],"exposure":[194],"CNS.":[197],"These":[198],"studies":[199],"show":[200],"that":[201],"models":[207],"related":[209],"potency":[212],"even":[213],"though":[214],"its":[215],"efflux.":[222],"Therefore,":[223],"comprehensive":[225],"understanding":[226],"all":[228],"aspects":[229],"warranted":[239],"discovery":[242],"development,":[244],"especially":[245],"treatment":[247]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4387599152","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":7},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2023-10-14T00:00:00"}
